General
Preferred name
VS-4718
Synonyms
PND-1186 ()
SR-2516 ()
PND 1186 ()
PND1186 ()
VS-4718 (hydrochloride) ()
SR-2516 (hydrochloride) ()
PND-1186 (hydrochloride) ()
PND-1186 (VS-4718) ()
SR-2156 ()
P&D ID
PD003237
CAS
1061353-68-1
1356154-94-3
Tags
available
drug candidate
Drug indication
Solid tumour/cancer
Drug Status
investigational
Max Phase
1.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
VS-4718 is an investigational, potent, reversible and orally active inhibitor of focal adhesion kinase (FAK; PTK2) . FAK inhibitors are being investigated for their anti-cancer effects due to the association of increased FAK expression with tumor progression, and the links between integrins and FAK in the adhesion pathways .
(GtoPdb)
DESCRIPTION
RIPK2 modulator; pro-drug of cRIPGM; orally bioavailable and brain penetrant
(Tocris Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
6
Organisms
0
Compound Sets
20
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugMAP
EU-OPENSCREEN Bioactive Compound Library
EUbOPEN Chemogenomics Library
Guide to Pharmacology
Kinase Inhibitors (best-in-class)
LINCS compound set
Mcule NIBR MoA Box Subset
Novartis Chemogenetic Library (NIBR MoA Box)
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
27
Molecular Weight
501.2
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
3
Rotatable Bonds
7
Ring Count
4
Aromatic Ring Count
3
cLogP
4.79
TPSA
87.75
Fraction CSP3
0.28
Chiral centers
0.0
Largest ring
6.0
QED
0.43
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
FAK
FAK/PYK2 inhibitor
Apoptosis related,FAK
Kinase group
TK
Pathway
Angiogenesis
Cytoskeletal Signaling
Tyrosine Kinase/Adaptors
Apoptosis
Protein Tyrosine Kinase/RTK
Primary Target
Focal Adhesion Kinase
MOA
Inhibitor
FAK inhibitor
focal adhesion kinase inhibitor
Member status
member
Recommended Cell Concentration
None
Source data